nitrosourea compounds

Preferred Label : nitrosourea compounds;

MeSH definition : A class of compounds in which the core molecule is R-NO, where R is UREA.;

MeSH synonym : compounds, nitrosourea;

MeSH annotation : DF: NITROSOUREA CPDS;

Is substance : O;

Details

Origin ID

D009607;

UMLS CUI

C0028210;

ATC code(s)
- nitrosoureas [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Nitrosoureas [ICD-11 Extension code]
CISMeF manual mappings
- Nitrosurea (substance) [SNOMED CT concept]
- Nitrosurea poisoning (disorder) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Medicinal product containing nitrosurea and acting as antineoplastic agent (product) [SNOMED CT concept]
- Nitrosourea Compound [NCIt concept]
- nitrosoureas [ATC Code]
Fils d'après SNOMED CT
- alkylating agents [MeSH Descriptor]
Record concept(s)
- nitrosourea compounds [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1,1-di-(2-bromoethyl)-4-nitroso-4-(2-chloroethyl)semicarbazide [MeSH Supplementary Concept]
- 1,1-di-(2-chloroethyl)-4-nitroso-4-(2-chloroethyl)semicarbazide [MeSH Supplementary Concept]
- 1,1-ethylenebis(1-nitrosourea) [MeSH Supplementary Concept]
- 1,3-bis(4-(4-ethyl-2,3-dioxo-1-piperazinyl)butyl)urea [MeSH Supplementary Concept]
- 1,3-dibutyl-1-nitrosourea [MeSH Supplementary Concept]
- 1-(2-(3-(2-chloroethyl)-3-nitrosoureido)ethyl)-3,4-dimethoxy-benzene [MeSH Supplementary Concept]
- 1-(2-(4-ethyl-2,3-dioxo-1-piperaziny)ethyl)-3-methylurea [MeSH Supplementary Concept]
- 1-(2-chloroethyl)-1-nitroso-3-(3-pyridylmethyl-1-oxy)urea [MeSH Supplementary Concept]
- 1-(2-chloroethyl)-1-nitroso-3-(4-thiomorpholino)urea [MeSH Supplementary Concept]
- 1-(2-chloroethyl)-1-nitroso-3-(methylene-2-pyridinyl)urea [MeSH Supplementary Concept]
- 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea [MeSH Supplementary Concept]
- 1-(2-chloroethyl)-3-(2-(5-fluoro-3-oxobenzoselenazol-2(3H)-yl)ethyl)-1-nitrosourea [MeSH Supplementary Concept]
- 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea [MeSH Supplementary Concept]
- 1-amyl-1-nitrosourea [MeSH Supplementary Concept]
- 1-methyl-1-(2-chloroethyl)-4-nitroso-4-(2-chloroethyl)semicarbazide [MeSH Supplementary Concept]
- 1-methyl-3-(4-bromophenyl)-1-nitrosourea [MeSH Supplementary Concept]
- 1-nitroso-1-(2-chloroethyl)-3-(2-hydroxypropyl)urea [MeSH Supplementary Concept]
- 1-nitroso-1-(2-hydroxyethyl)-3-(2-chloroethyl)urea [MeSH Supplementary Concept]
- 1-nitroso-1-(2-hydroxyethyl)-3-ethylurea [MeSH Supplementary Concept]
- 1-nitroso-1-(2-hydroxypropyl)-3-(2-chloroethyl)urea [MeSH Supplementary Concept]
- 1-nitroso-1-ethyl-3-(2-hydroxyethyl)urea [MeSH Supplementary Concept]
- 2-((((2-chloroethyl)-nitrosoamino)carbonyl)amino)-1,3-cyclohexanediol [MeSH Supplementary Concept]
- 2-((3-chloroethyl)-3-nitrosoureido)glucopyranose [MeSH Supplementary Concept]
- 2-amino-2-deoxy-N'-methyl-N'-nitrosoureido-1,3,4,6-tetra-O-acetylmannopyranose [MeSH Supplementary Concept]
- 3' (3-(2-chloroethyl)-3-nitrosoureido)-2',3'-dideoxyuridine [MeSH Supplementary Concept]
- 3'-(3-(2-chloroethyl)-3-nitrosoureido)-2',3'-dideoxy-5-fluorouridine [MeSH Supplementary Concept]
- 3-(2-(3-(2-chloroethyl)-3-nitrosouriedo)ethyl)spiro(5,9'-fluorenyl)imidazolidiine-2,4-dione [MeSH Supplementary Concept]
- 3-arabinopyranosyl-1-methyl-1-nitrosourea [MeSH Supplementary Concept]
- 4-(N-(2-chloroethyl)-N-nitrosocarbamoyl)morpholine [MeSH Supplementary Concept]
- 6-bromo-2-(2-(3-(2-chloroethyl)-3-nitrosoureido)ethyl)-1H-benz-(de)isoquinoline-1,3-dione [MeSH Supplementary Concept]
- 6-chloro-2-(2-(3-(2-chloroethyl)-3-nitrosoureido)ethyl)-1H-benz-(de)isoquinoline-1,3-dione [MeSH Supplementary Concept]
- B 3839 [MeSH Supplementary Concept]
- CGP 6809 [MeSH Supplementary Concept]
- CHOP-V-MMV protocol [MeSH Supplementary Concept]
- FCT protocol [MeSH Supplementary Concept]
- FD137 nitrosourea [MeSH Supplementary Concept]
- GCNU [MeSH Supplementary Concept]
- GYKI 13324 [MeSH Supplementary Concept]
- GYKI 13485 [MeSH Supplementary Concept]
- I 278 [MeSH Supplementary Concept]
- ICIG 1163 [MeSH Supplementary Concept]
- LSG15 regimen [MeSH Supplementary Concept]
- MCNU-VMP protocol [MeSH Supplementary Concept]
- MCPP protocol [MeSH Supplementary Concept]
- MECHOP-BM protocol [MeSH Supplementary Concept]
- MMPP protocol [MeSH Supplementary Concept]
- N'-(2-chloroethyl)-N-(2-(methylsulfinyl)ethyl)-N'-nitrosourea [MeSH Supplementary Concept]
- N'-(2-chloroethyl)-N-(2-(methylsulfonyl)ethyl)-N'-nitrosourea [MeSH Supplementary Concept]
- N'-(N-(2-chloroethyl)-N-nitroso)carbamoylcysteamine [MeSH Supplementary Concept]
- N(delta)-(N-methyl-N-nitrosocarbamoyl)-L-ornithine [MeSH Supplementary Concept]
- N,N'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine [MeSH Supplementary Concept]
- N,N'-bis(4-hydroxycyclohexyl)-N'-nitrosourea [MeSH Supplementary Concept]
- N,N-dimethylaminoethylnitrosoethylurea [MeSH Supplementary Concept]
- N-(2-chloroethyl)-N-carbamoylprolinamide [MeSH Supplementary Concept]
- N-(2-chloroethyl)-N-nitrosocarbamoyl-omega-lysine [MeSH Supplementary Concept]
- N-(2-chloroethyl)-N-nitrosocarbamoylglycinamide [MeSH Supplementary Concept]
- N-(2-chloroethyl)-N-nitrosocarbamoylvalinamide [MeSH Supplementary Concept]
- N-(2-chloroethyl)-N-nitrosoureidodaunorubicin [MeSH Supplementary Concept]
- N-(2-hydroxypropyl)-N-nitrosourea [MeSH Supplementary Concept]
- N-(2-oxopropyl)-N-nitrosourea [MeSH Supplementary Concept]
- N-(3-hydroxypropyl)-N-nitrosourea [MeSH Supplementary Concept]
- N-(N'-(2-chloroethyl)--N'-nitrosocarbamoyl)methionine-dihydrotestosterone-17-ester [MeSH Supplementary Concept]
- N-(N'-(2-chloroethyl)-N'--nitrosocarbamoyl)methionine-testosterone-17-ester [MeSH Supplementary Concept]
- N-benzylnitrosourea [MeSH Supplementary Concept]
- N-carboxymethyl-N-nitrosourea [MeSH Supplementary Concept]
- N-isobutyl-N-nitrosourea [MeSH Supplementary Concept]
- N-neopentyl-N-nitrosourea [MeSH Supplementary Concept]
- N-nitrosobutylurea [MeSH Supplementary Concept]
- N-nitrosoethylenethiourea [MeSH Supplementary Concept]
- NSC 634775 [MeSH Supplementary Concept]
- NSC-114460 [MeSH Supplementary Concept]
- PMV protocol [MeSH Supplementary Concept]
- RFCNU [MeSH Supplementary Concept]
- ROAD-IN protocol [MeSH Supplementary Concept]
- TA 077 [MeSH Supplementary Concept]
- acetamido-CNU [MeSH Supplementary Concept]
- bis(N-carbamyl-N-nitroso)hexamethylenediamine [MeSH Supplementary Concept]
- bis-(fluoroethyl)nitrosourea [MeSH Supplementary Concept]
- diethylmethylnitrosourea [MeSH Supplementary Concept]
- ecomustine [MeSH Supplementary Concept]
- elmustine [MeSH Supplementary Concept]
- fotemustine [MeSH Supplementary Concept]
- lysomustine [MeSH Supplementary Concept]
- methyl 3,4-dideoxy-3-(2-chloroethyl)nitrosoureidoglucoside [MeSH Supplementary Concept]
- nitrullin [MeSH Supplementary Concept]
- propylnitrosourea [MeSH Supplementary Concept]
- ranimustine [MeSH Supplementary Concept]
- triethylnitrosourea [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Medicinal product containing nitrosurea and acting as antineoplastic agent (product) [SNOMED CT concept]
- Nitrosourea Compound [NCIt concept]
- Nitrosurea (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients